Cellectar Biosciences Inc. (CLRB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cellectar Biosciences Inc...

    NASDAQ: CLRB · Real-Time Price · USD
    5.29
    0.26 (5.17%)
    At close: Sep 09, 2025, 3:59 PM
    5.15
    -2.65%
    Pre-market: Sep 10, 2025, 06:37 AM EDT

    Cellectar Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -51.78M -38.96M -28.81M -24.13M
    Interest Income
    		 1.21M 387.15K 152.52K 2.28K
    Pretax Income
    		 -44.52M -42.83M -31.85M -24.12M
    Net Income
    		 -44.58M -42.77M -31.79M -24.12M
    Selling & General & Admin
    		 25.64M 11.5M 9.59M 6.54M
    Research & Development
    		 26.14M 27.47M 19.22M 17.59M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 51.78M 38.96M 28.81M 24.13M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 51.78M 38.96M 28.81M 24.13M
    Income Tax Expense
    		 66K -60K -60K n/a
    Shares Outstanding (Basic)
    		 1.54M 647.37K 310.2K 185.05K
    Shares Outstanding (Diluted)
    		 1.54M 647.37K 310.2K 185.05K
    EPS (Basic)
    		 -40.72 -104.92 -473.55 -130.35
    EPS (Diluted)
    		 -45.38 -104.92 -473.55 -130.35
    EBITDA
    		 -51.49M -38.77M -28.67M -23.98M
    EBIT
    		 -51.78M -38.96M -28.81M -24.12M
    Depreciation & Amortization
    		 291.65K 192.38K 148.44K 149.91K

    Add to Watchlist